Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii.

Johnson LL, Lanthier P, Hoffman J, Chen W.

Vaccine. 2004 Sep 28;22(29-30):4054-61.

PMID:
15364456
2.
3.

Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.

Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.

Parasite Immunol. 2005 Jan-Feb;27(1-2):29-35.

PMID:
15813720
4.

Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.

Schlüter D, Kwok LY, Lütjen S, Soltek S, Hoffmann S, Körner H, Deckert M.

J Immunol. 2003 Jun 15;170(12):6172-82.

7.

A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.

Liu Q, Gao S, Jiang L, Shang L, Men J, Wang Z, Zhai Y, Xia Z, Hu R, Zhang X, Zhu XQ.

Microbes Infect. 2008 Oct;10(12-13):1355-62. doi: 10.1016/j.micinf.2008.08.002. Epub 2008 Aug 12.

PMID:
18761418
8.
9.

Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1.

Mishima M, Xuan X, Shioda A, Omata Y, Fujisaki K, Nagasawa H, Mikami T.

J Vet Med Sci. 2001 Apr;63(4):433-8.

10.

Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts.

Lindsay DS, Lenz SD, Dykstra CC, Blagburn BL, Dubey JP.

J Parasitol. 1998 Apr;84(2):311-5.

PMID:
9576504
11.

Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents.

Angus CW, Klivington-Evans D, Dubey JP, Kovacs JA.

J Infect Dis. 2000 Jan;181(1):317-24.

12.

The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis.

Lu F, Huang S, Kasper LH.

Vaccine. 2009 Jan 22;27(4):573-80. doi: 10.1016/j.vaccine.2008.10.090. Epub 2008 Nov 19.

PMID:
19026704
13.

Induction of protective immunity by primed B-1 cells in Toxoplasma gondii -infected B cell-deficient mice.

Chen M, Mun HS, Piao LX, Aosai F, Norose K, Mohamed RM, Belal US, Fang H, Ahmed AK, Kang HK, Matsuzaki G, Kitamura D, Yano A.

Microbiol Immunol. 2003;47(12):997-1003.

PMID:
14695450
14.

[Oral mixed DNA vaccine protects mice from infection of Toxoplasma gondii].

Cong H, Gu QM, Zhou HY, Guo L, Yang TT, He SY, Li Y, Zhao QL.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005 Jun 30;23(3):159-62. Chinese.

PMID:
16300008
15.

DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.

Vercammen M, Scorza T, Huygen K, De Braekeleer J, Diet R, Jacobs D, Saman E, Verschueren H.

Infect Immun. 2000 Jan;68(1):38-45.

16.

Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines.

Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD.

J Immunol. 2001 Oct 15;167(8):4574-84.

17.
18.
19.

Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.

Dimier-Poisson I, Aline F, Bout D, Mévélec MN.

Vaccine. 2006 Mar 6;24(10):1705-9. Epub 2005 Oct 10.

PMID:
16256251
20.

Toxoplasma gondii: effect of sublethal irradiation on host resistance in mice.

Johnson LL, Gibson GW, Sayles PC.

Exp Parasitol. 1995 Sep;81(2):172-81.

PMID:
7556559
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk